Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 6

Retroperitoneal inflammatory pseudotumor

Pages
1133–1135
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

YILDIRIM, N., ADAY, U., GÜLTÜRK, B., BOYUK, A. (2022). Retroperitoneal inflammatory pseudotumor. Annals of Medical Research, Cilt: 26 - Sayı: 6, 1133–1135. https://ajindex.com/articles/441629

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Surabhi VR, Chua S, Patel RP, et al. Inflammatory myofibroblastic tumors: current update. Radiol Clin North Am 2016;54:553-63
  2. Sedlic T, Scali EP, Lee WK, et al. Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J 2014;65:52-9
  3. Patnana M, Sevrukov AB, Elsayes KM, et al. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 2012;198:217-27
  4. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991;15:1146-56
  5. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19:859-72
  6. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008;61:428-37
  7. Kovach SJ, Fischer AC, Katzman PJ, et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006;94:385-91
  8. Wang Z, Zhao X, Li K, et al. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatr Surg Int 2016;32:239-243
  9. Yagmur Y, Akbulut S, Gumus S. Mesenteric inflammatory pseudotumor: a case report and comprehensive literature review. J Gastrointest Cancer 2014;45:414-20
  10. Lovly CM, Gupta A, Lipson D, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov 2014;4:889-95
  11. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509-20.